Visión generalGráficoPerfilEstadísticas claveBalance generalNoticiasTraderScreen

TERUMO CORP./  JP3546800008  /

gettex
07/11/2024  17:13:33 Diferencia -0.400 Volumen Bid07/11/2024 Ask07/11/2024 Capitalización de mecado Dividendo A. P/E Ratio
17.800EUR -2.20% -
Volumen de negocios: -		 17.600Volumen de oferta: 70 18.000Tamaño/ Volumen/ Formato de Ask: 70 26.54 mil millonesEUR - -
GlobeNewswire 12/08 Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 30/07 Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board o...
GlobeNewswire 10/07 Terumo Blood and Cell Technologies celebrates 60 years as a community-first Colorado company
GlobeNewswire 10/06 Over 80 Organizations Kick Off Blood Advocacy Week by Urging Congress to Support the Blood Supply as...
GlobeNewswire 04/06 Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Le...
GlobeNewswire 22/05 Orchestra BioMed to Participate in Jefferies Global Healthcare Conference
GlobeNewswire 13/05 Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 09/05 R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new Pre...
GlobeNewswire 30/04 Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Paten...
GlobeNewswire 30/04 Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacem...
GlobeNewswire 02/04 Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
GlobeNewswire 26/03 Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of D...
GlobeNewswire 13/03 Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy ...
GlobeNewswire 07/03 Orchestra BioMed to Participate in Upcoming Investor Conferences
GlobeNewswire 06/03 Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemod...
GlobeNewswire 26/02 Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambu...
GlobeNewswire 20/02 TransPerfect’s GlobalLink/Adobe Experience Manager (AEM) Integration Adds 30+ Global Brands in 2023
GlobeNewswire 08/01 Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pace...
GlobeNewswire 13/11/2023 Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 09/11/2023 Orchestra BioMed to Present at Upcoming Investor Conferences
GlobeNewswire 19/09/2023 Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for...
GlobeNewswire 24/08/2023 NeurAxis Highlights Strength of its Board of Directors
GlobeNewswire 03/02/2022 Applied Science, Inc. Announces New Vice President of Sales, Marketing & Customer Care, Ral Trujillo
GlobeNewswire 17/12/2021 Sigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Authorized COVID-19 Therapie...
GlobeNewswire 18/11/2021 Terumo Corporation and Diabeloop SA Enter Into Comprehensive Strategic Partnership Agreement to Expa...